However, this number was compounded by the exclusion of 41 patients, 28% of those recruited because of poor quality or inadequate DNA, in addition to which 20–30% of chondrosarcomas which do not harbour an IDH1/2 alteration [12]. Here, IDH1 is linked to chondrosarcoma.